Founder of this publicly listed pharmaceutical company has a net worth of Rs 51,887 crore; here's why
He is India’s 20th richest person.
Murli K Divi, founder of Divi’s Laboratories Ltd is India’s 20th richest person according to Forbes’s richest person list. As of August 30, 2022, he has a net worth of Rs 51,887 crore.
He has done postgraduation in Pharmaceutical Chemistry from College of Pharmacy, Manipal. Before starting Divi's Laboratories Ltd, Dr Divi worked with Trinity Chemical Corporation, US, Schuylkill Chemical US and Fike Chemicals (as Technical Director and Vice President (R&D) US). Presently, Murli is the Managing Director (MD) of the company.
Divi’s Laboratories Limited is a publicly listed company, having a market capitalisation of Rs 95197 crore.
Divi’s Laboratories Limited is one of the leading pharmaceutical companies in the world, manufacturing Active Pharmaceutical Ingredients (APIs), Intermediates and Nutraceuticals. It has two manufacturing plants, one in Visakhapatnam and the other in Hyderabad.
The company has a strong presence in the international market. About 88% of the company’s revenue comes from its export business. The company has a core competency in custom synthesis under contract manufacturing of APIs. Pfizer, Merck, and GSK are a few of its clients.
About FY22 financial performance, the company’s total revenue stood at Rs 8993.85 crore, a 31% increase from Rs 6862 crore in FY21. FY22 net profit also improved by 50.84% from Rs 1954 crore in FY21 to Rs 2948 crore.
Over the past decade, it has constantly been able to deliver high ROE and ROCE numbers. Currently, as per the FY22 period ending, the company has an ROE and ROCE of 28.2% and 35.1%, respectively.
About the shareholding pattern, 51.94% of the stake is owned by the promoters, 16.52% by FIIs, 19.98% by DIIs, and the rest 11.56% by non-institutional investors.
On August 30, at 11 am, the shares of Divi’s Laboratories Ltd are trading at Rs 3601.45 with a 0.46% gain for the day. The scrip has a 52-week high and low of Rs 5425 and Rs 3365.1, respectively.
About the Author
DisclaimerInvestment/Trading in securities Market is subject to market risk, past performance is not a guarantee of future performance. The risk of loss in trading and investment in Securities markets including Equites and Derivatives can be substantial.
Start Investing Now!
Open Free Demat Account in 5 mins